Ionis Pharmaceuticals | IONS - Actif À Court Terme





Actif À Court Terme Changement Date
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Astellas Pharma JPY 1.49T 63.68B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Celltrion KRW 481.57B 10.97B 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Exelixis USD 1.25B 42.18M 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 27.35B 744M 2026-06
Omeros USD 69.65M 26.53M 2025-06
OPKO Health USD 535.36M 46.52M 2026-03
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pfizer USD 41.36B 1.46B 2026-06
Pharma Mar EUR 280.95M 7.5M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.16B 270.46M 2026-06